NCT00426816 - To Evaluate The Effects Of SB-649868 (10, 30 Mg And 60 Mg) On Subjects With Primary Insomnia | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 31, 2006

Primary Completion Date

May 31, 2007

Study Completion Date

May 31, 2007

Conditions

Sleep Initiation and Maintenance Disorders

Interventions

DRUG

SB-649868

Active compound at doses of 10mg, 30mg and 60mg

DRUG

Placebo

Placebo to match SB-649868

Trial Locations (10)

GSK Investigational Site, Berlin

GSK Investigational Site, Berlin

GSK Investigational Site, Berlin

GSK Investigational Site, Schwerin

GSK Investigational Site, Hamburg

GSK Investigational Site, Dortmund

GSK Investigational Site, Münster

GSK Investigational Site, Mannheim

GSK Investigational Site, Cottbus

GSK Investigational Site, Dresden